To compare the efficacy of topical 0.1% Betamethasone valerate and fractional co2 laser with topical 0.1% Betamethasone valerate in treatment of Alopecia areata
Not Applicable
- Conditions
- Health Condition 1: L639- Alopecia areata, unspecified
- Registration Number
- CTRI/2023/07/055395
- Lead Sponsor
- Dr KVignesh kumar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patient with alopecia areata patients will be divided into Group A & Group B. Each group comprising of 40 patients. 40 patients in Group A will be use topical 0.1% betamethasone alone 40 patients in Group B will treated with fractional co2 with topical 0.1% betamethasone. Maximum 6 sittings will be given at 2 weeks interval. Patient will receive no other therapies during study
Exclusion Criteria
Before starting the study
Pregnant and lactating women.
Women planning for pregnancy
Children less than 14 years
During Study
If patient wants alternate treatment during the study.
If patient wants to discontinue the treatment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method